Table 4.
Author | Follow-Up Duration | Mortality | Aorta-Related Death | TV Patency | Re-Interventions | Endoleak | Reasons for Re-Intervention |
---|---|---|---|---|---|---|---|
Redlinger et al. [14] | 11 (1–40) | 2 | 0 | 100% | 2 | 2 | Coils for ET II from LSA |
Liu et al. [15] | 10.5 ± 5.7 | 0 | 0 | 100% | NA | 0 | |
Sonesson et al. [16] | 27 | 2 | 1 | 100% | 1 | 2 | Type Ic from LSA |
Yan et al. [17] | 16 (3–26) | 1 | NA | NA | 0 | 3 | |
Li et al. [18] | 15 ± 5 | 2 | 0 | 100% | 1 | 7 | Type Ib endoleak, extension LSA |
Evans et al. [19] | 9 (1–29) | 3 | 0 | 9 | 6 | 6 embolization and extension for ET III, 1 angioplasty for bypass stenosis, 1 bypass for endoleak, 1 hematoma |
Footnotes: ET: endoleak type; LSA: left subclavian artery; NA: non-applicable; TV: target vessel.